
Attendees can take advantage of many satellite symposia, sponsored by industry and feauring experts from around the world
Attendees can take advantage of many satellite symposia, sponsored by industry and feauring experts from around the world
Experts in all aspects of retinal care will gather at the RAI Amsterdam Convention Centre, located in the Zuidas business district of the city, which is a short distance from historic Amsterdam with is canals, museums, and shops
Research from Orbis International analyses the overall wellbeing of children with common childhood vision problems
Stem cells may replace some lost retinal neurons
The AI retinal scanning model will be free to use for all institutions
MERCURY-3 trial data show latanoprost/netarsudil fixed-dose combination (Roclanda) demonstrated comparable IOP lowering efficacy to bimatoprost/timolol combination, in patients with primary open-angle glaucoma or ocular hypertension.
Novartis acquired Gyroscope Holdings Limited from Syncona in February 2022
According to Bausch + Lomb, MIEBO (perfluorohexyloctane ophthalmic solution), commercialised as EvoTears in Europe, is the first prescription eye drop that targets tear evaporation.
The company has 9 presentations at the annual congress of the European Society of Cataract and Refractive Surgeons being held in Vienna. AVG also is a sponsor of the International Society of Presbyopia.
OWL's ESCRS 2023 event on Sunday, September 10, at 7 pm, promises an evening of visionary leadership and collaboration in ophthalmic innovation.
The non-profit will partner with the imaging company to prevent blindness and fund new retinoblastoma research.
The company announced new data on outcomes for both open and narrow angle glaucoma patients.
Reviewing visual and anatomic outcomes in 2 clinical trials
Lenticule extraction poses a provocative question–and a complicated answer
According to the company, the deal expands its European footprint into Spain and Portugal.
One of AI’s most promising applications: new diagnostic algorithms
Advancements from Carl Zeiss Medical AG in the cataract and cornea space include a new intraocular lens and therapeutic laser enhancements.
The new platform incorporates the SILK procedure, allowing surgeons to perform refractive correction on patients with myopia.
The EUREQUO Annual Report celebrates 15 years and over 4 million surgical procedures in the registry.
According to the company, it is working with the FDA to address the agency’s issues.
ATSN-201 leverages novel spreading capsid to overcome challenges associated with intravitreally delivered AAVs in the treatment of XLRS.
OCT methods are invaluable in the assessment of patients with the condition
Commonly used immunosuppressants used in the short term to control an ocular inflammatory disease were not associated with increased risk of developing cancer later.
Surgeon discusses latest trends for treating cornea
This intellectual property protects Kiora's pipeline by covering several inflammatory-related therapeutic applications, including posterior non-infectious uveitis.
A multicentre study demonstrates comparable results to FS-LASIK
VG901 is a gene therapy for CNGA1-associated RP.
Researchers have identified markers that indicate the presence of Parkinson disease in patients an average of 7 years before the disease presents clinically.
The first-line treatment to avoid visual impairment for these cases is anti-vascular endothelial growth factor therapy (VEGF).